Sun.Aug 04, 2024

article thumbnail

Biotech Financing Roundup: Jade Bio’s Launch, Brenig’s Debut, Confo’s Cash & More

MedCity News

Recent financing news includes several companies raising money to advance their research to the clinic. Here’s a look back at funding rounds from companies such as Outpace Bio, GRO Biosciences, and Confo Therapeutics. The post Biotech Financing Roundup: Jade Bio’s Launch, Brenig’s Debut, Confo’s Cash & More appeared first on MedCity News.

Biopharma 115
article thumbnail

Sales Team Management: 24 Practical Strategies You Need to Know

Spotio

Let’s be honest, managing a high-performance sales team is hard. Especially when you consider that 91% of sales reps missed their sales quotas last year. How can anyone be expected to lead a group of sellers effectively when almost all of them are likely to underperform in some way? Missed quotas aren’t even the worst of it. The average annual turnover rate for sales teams is a whopping 35%.

Sales 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Quiet Epidemic Affecting Vascular Health

MedCity News

Peripheral IV insertion and blood collection are two of the most prevalent inpatient procedures in U.S. hospitals. Here’s how clinicians can advocate for a better, more compassionate care experience without extra “sticks.” The post The Quiet Epidemic Affecting Vascular Health appeared first on MedCity News.

106
106
article thumbnail

FDA panel backs Zevra's arimoclomol, after earlier rejection

pharmaphorum

An FDA advisory committee has recommended approval of Zevra Therapeutics' arimoclomol for the ultra-rare disorder Niemann-Pick disease, three years after the regulator rejected the drug.The Genetic Metabolic Diseases Advisory Committee (GeMDAC) voted 11 to five that the data support the approval of the drug for Niemann-Pick disease type C (NPC), a progressive genetic disorder that leads to the accumulation of fatty substances in tissues and can cause a range of symptoms, including liver and lung

FDA 79
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Centering Cultural Sensitivity in Applied Behavior Analysis

MedCity News

Families of autistic children from underrepresented communities often face the dual challenge of navigating their child’s diagnosis while feeling overlooked by healthcare and therapy systems. How can ABA adapt to meet the needs of an evolving population? The post Centering Cultural Sensitivity in Applied Behavior Analysis appeared first on MedCity News.

article thumbnail

Biopharmaceutical Frontiers

PharmaTech

Daniel Galbraith, Chief Scientific Officer (CSO) of Solvias provided a comprehensive picture to Pharmaceutical Technology of the current landscape of cell and gene therapy advancements. The discussion covers important regulatory guidance, technological landmarks, and how Solvias is impacting the current market.

More Trending

article thumbnail

Zuranolone Offers An Innovative Treatment for Postpartum Depression

Pharmacy Times

Zuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.

article thumbnail

What Investors Have to Say About Digital Health’s Newly Stable Funding Environment

MedCity News

Digital health investors agree that the market is settling into a steady investment pace, as well as returning to reasonable valuations. Only time will tell if this can bolster the tepid rate of exit activity in the sector. The post What Investors Have to Say About Digital Health’s Newly Stable Funding Environment appeared first on MedCity News.

Marketing 104